| Mason-dixon Mobile Medicine | |
|
723 N Market St Frederick MD 21701-5232 | |
| (240) 397-6723 | |
| (833) 992-0865 |
| Full Name | Mason-dixon Mobile Medicine |
|---|---|
| Speciality | Family Medicine |
| Location | 723 N Market St, Frederick, Maryland |
| Authorized Official Name and Position | Douglas H. Brown (PRIMARY MEMBER) |
| Authorized Official Contact | 2403976723 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mason-dixon Mobile Medicine 723 N Market St Frederick MD 21701-5232 Ph: (240) 397-6723 | Mason-dixon Mobile Medicine 723 N Market St Frederick MD 21701-5232 Ph: (240) 397-6723 |
| NPI Number | 1073142147 |
|---|---|
| Provider Enumeration Date | 04/02/2020 |
| Last Update Date | 01/11/2022 |
| Medicare PECOS PAC ID | 3476982901 |
|---|---|
| Medicare Enrollment ID | O20200406000363 |
News Archive
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.
While it is well known that starfish, zebrafish and salamanders can re-grow damaged limbs, scientists understand very little about the regenerative capabilities of mammals. Now, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report on the regenerative process that enables rats to re-grow their bladders within eight weeks.
Vertical*i, and Inova SA today announced they have entered into a merger agreement effective December 6, 2010. The combined company will be known as Inova Software Inc, in North America and Inova Software, SA in Europe.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073142147 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Joseph E Asuncion |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225009400 PECOS PAC ID: 1355480336 Enrollment ID: I20091204000112 |
News Archive
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.
While it is well known that starfish, zebrafish and salamanders can re-grow damaged limbs, scientists understand very little about the regenerative capabilities of mammals. Now, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report on the regenerative process that enables rats to re-grow their bladders within eight weeks.
Vertical*i, and Inova SA today announced they have entered into a merger agreement effective December 6, 2010. The combined company will be known as Inova Software Inc, in North America and Inova Software, SA in Europe.
› Verified 3 days ago
| Provider Name | Rachel E Ondrish |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285106674 PECOS PAC ID: 9638411176 Enrollment ID: I20190501003383 |
News Archive
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.
While it is well known that starfish, zebrafish and salamanders can re-grow damaged limbs, scientists understand very little about the regenerative capabilities of mammals. Now, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report on the regenerative process that enables rats to re-grow their bladders within eight weeks.
Vertical*i, and Inova SA today announced they have entered into a merger agreement effective December 6, 2010. The combined company will be known as Inova Software Inc, in North America and Inova Software, SA in Europe.
› Verified 3 days ago
| Provider Name | Mary Mcdonald |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1356447692 PECOS PAC ID: 2961474135 Enrollment ID: I20230501001127 |
News Archive
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.
While it is well known that starfish, zebrafish and salamanders can re-grow damaged limbs, scientists understand very little about the regenerative capabilities of mammals. Now, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report on the regenerative process that enables rats to re-grow their bladders within eight weeks.
Vertical*i, and Inova SA today announced they have entered into a merger agreement effective December 6, 2010. The combined company will be known as Inova Software Inc, in North America and Inova Software, SA in Europe.
› Verified 3 days ago
News Archive
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.
While it is well known that starfish, zebrafish and salamanders can re-grow damaged limbs, scientists understand very little about the regenerative capabilities of mammals. Now, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report on the regenerative process that enables rats to re-grow their bladders within eight weeks.
Vertical*i, and Inova SA today announced they have entered into a merger agreement effective December 6, 2010. The combined company will be known as Inova Software Inc, in North America and Inova Software, SA in Europe.
› Verified 3 days ago
Hillcrest School Based Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1285 Hillcrest Dr, Frederick, MD 21703 Phone: 240-236-3275 Fax: 240-236-3293 | |
Lourdes Brigida Hunter Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 Thomas Johnson Dr, Suite 104, Frederick, MD 21702 Phone: 301-360-0776 Fax: 301-631-8443 | |
Sivimed Internal Medicine Associates Nd Primary Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 141 Thomas Johnson Dr Ste 100, Frederick, MD 21702 Phone: 301-228-9123 Fax: 855-760-5009 | |
Premise Health Of Maryland Medical P C Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7407 Willow Rd, Frederick, MD 21702 Phone: 301-624-5270 Fax: 334-625-4520 | |
Premise Health Of Maryland Medical P C Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9021 Bennett Creek Blvd, Frederick, MD 21704 Phone: 240-346-3549 | |
Serenity Medical & Wellness Center Of Frederick Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 801 Toll House Ave, Suite F1, Frederick, MD 21701 Phone: 240-561-5163 |